Everest Medicines Receives the NMPA Recommendation of Priority Review for Cefepime-Taniborbactam to Treat Complicated Urinary Trac...
September 20, 2023
Everest Medicines Partner Calliditas Publish P-III (NeflgArd) Trial Results of Nefecon for Primary IgA Nephropathy in The Lancet
August 18, 2023
PharmaShots Weekly Snapshots (July 24 – 28, 2023)
July 29, 2023
Everest Medicines Reports the Commercial Availability of Xerava (eravacycline) in China
July 27, 2023
Everest Medicines Signed a MoU with Shanghai Pharma Subsidiary to Advance the Commercialization of Xerava (eravacycline) in Mainla...
April 19, 2023
Singapore HSA Accepts NDA of Everest Medicines’ Nefecon for the Treatment of Primary IgA Nephropathy
April 6, 2023
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.